Comparative Analysis of Ribosomal Protein Gene, eL14 Expression between Two Types of Colorectal Carcinoma Cell Lines
Abstract
Association between expression of ribosomal protein (RP) genes and cancer is widely known. More specifically, the extra-ribosomal functions of RPs have been linked to carcinogenesis. The ribosomal protein gene, eL14 has been reported to be associated with malignancy of the colorectum, albeit of mechanism yet unclear. Its activity in cells derived from different tissue origin of colorectal carcinoma (CRC) has never been explored. Therefore, this study aims to comparatively analyse the expression pattern of eL14 between two different CRC cell lines (DLD-1 and HCT116). It involved a conventional gene expression analysis, the Reverse-Transcriptase PCR (RT-PCR) assays. Products of RT-PCR assay were resolved via an Agarose Gel Eectrophoresis method, and band intensities of amplicons were documented and quantified using TotalLab Quant software. We observed differential expression pattern of eL14 between DLD-1 and HCT116 cells, but statistical analysis revealed insignificant differences. Therefore, the relevance of eL14 as a biomarker to distinguish between different colorectal cancer cells is suggestive but not conclusive.
References
Brattain, M. G., Fine, D. W., Khaled, M., Thompson, J., & Brattain, D. E. (1981). Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Research, 41, 1751-1756.
Chen, J. W., Wei, Y., Feng, Q. Y., Ren, L., He, G. D., Chang, W. J., Zhu, D., Yi, T., Lin, Q., Tang, W., & Xu, J. (2016). Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway. International Journal of Oncology, 48(4), 1628-1638.
https://doi.org/10.3892/ijo.2016.3366
Chomczynski, P., & Sacchi, N. (1987). Single-step method of RNA extraction by acid guanidinium thiocynate-phenol-chloroform extraction. Analytical Biochemistry, 162(1), 156-159.
https://doi.org/10.1016/0003-2697(87)90021-2
Dexter, D. L., Spremulli, E. N., Fligiel, Z., Barbosa, J. A., Vogel, R., VanVoorhees, A., & Calabresi, P. (1981). Heterogeneity of cancer cells from a single human colon carcinoma. The American Journal of Medicine, 71(6), 949-956.
https://doi.org/10.1016/0002-9343(81)90312-0
Huang, X. P., Zhao, C. X., Li, Q. J., Cai, Y., Liu, F. X., Hu, H., Xu, X., Han, Y.L., Wu, M., Zhan, Q.M., & Wang, M. R. (2006). Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus. Gene, 366(1), 161-168.
https://doi.org/10.1016/j.gene.2005.09.025
Liu, Y. F., Zhu, X. J., Zhu, J., Liao, S. B., Liu, K. K., Guan, X. H., Zhang, J., & Feng, Z. Q. (2007). Identification of different expression of genes in hepatocellular carcinoma by suppression subtractive hybridisation combined cDNA microarray. Oncology Reports, 18, 943-951.
https://doi.org/10.3892/or.18.4.943
Ruggero, D., & Pandolfi P. P. (2003). Does the ribosome translate cancer? Nature Reviews Cancer, 3, 179-192.
https://doi.org/10.1038/nrc1015
Schneider, M., Huber, J., Hadaschik, B., Siegers, G. M., Fiebig, H. H., & Schüler, J. (2012). Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer, 12, 96.
https://doi.org/10.1186/1471-2407-12-96
Shriver, S. P., Shriver, M. D., Tirpak, D. L., Bloch, L. M., Hunt, J. D., Ferrell, R. E., & Siegfried, J. M. (1998). Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): Localisation to 3p21.3 and loss of heterozygosity in lung and oral cancers. Mutation Research Genomics, 406 (1), 9-23.
https://doi.org/10.1016/S1383-5726(98)00006-5
Sim, E. U. H., Chee, C. S. M., Vasudevan, L., Ng, K. H., & Chan, S. L. L. (2018). Selective differential expression of the ribosomal protein genes eL14 and uS19 in a well-differentiated epithelial cell line of nasopharyngeal carcinoma. Malaysian Applied Biology Journal, 47 (1), 247-253.
Sim, E. U. H., Mutsamy, S., & Teh, Z. Y. (2020). Expression patterns of the human ribosomal protein genes eL14 and uS19 in colon cancer is dependent on the type and stage of the cancer cell. Malaysian Applied Biology Journal, 49(3), in press.
Wahab, R., Gopalan, V., Islam, F., Smith, R. A., Qiao, B., & Lam, A. K. (2017). Cellular expression, in-vitro ad in-vivo confirmation of GAEC1 oncogenic properties in colon cancer. European Journal of Cell Biology, 96(6), 487-495.
https://doi.org/10.1016/j.ejcb.2017.07.003
Wang, W., Nag, S., Zhang, X., Wang, M. H., Wang, H., Zhou, J. W., & Zhang R. W. (2014). Ribosomal proteins and human disease: Pathogenesis, molecular mechanisms, and therapeutic implications. Medical Research Reviews, 35(2), 225-285.
Copyright Transfer Statement for Journal
1) In signing this statement, the author(s) grant UNIMAS Publisher an exclusive license to publish their original research papers. The author(s) also grant UNIMAS Publisher permission to reproduce, recreate, translate, extract or summarize, and to distribute and display in any forms, formats, and media. The author(s) can reuse their papers in their future printed work without first requiring permission from UNIMAS Publisher, provided that the author(s) acknowledge and reference publication in the Journal.
2) For open access articles, the author(s) agree that their articles published under UNIMAS Publisher are distributed under the terms of the CC-BY-NC-SA (Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work of the author(s) is properly cited.
3) For subscription articles, the author(s) agree that UNIMAS Publisher holds copyright, or an exclusive license to publish. Readers or users may view, download, print, and copy the content, for academic purposes, subject to the following conditions of use: (a) any reuse of materials is subject to permission from UNIMAS Publisher; (b) archived materials may only be used for academic research; (c) archived materials may not be used for commercial purposes, which include but not limited to monetary compensation by means of sale, resale, license, transfer of copyright, loan, etc.; and (d) archived materials may not be re-published in any part, either in print or online.
4) The author(s) is/are responsible to ensure his or her or their submitted work is original and does not infringe any existing copyright, trademark, patent, statutory right, or propriety right of others. Corresponding author(s) has (have) obtained permission from all co-authors prior to submission to the journal. Upon submission of the manuscript, the author(s) agree that no similar work has been or will be submitted or published elsewhere in any language. If submitted manuscript includes materials from others, the authors have obtained the permission from the copyright owners.
5) In signing this statement, the author(s) declare(s) that the researches in which they have conducted are in compliance with the current laws of the respective country and UNIMAS Journal Publication Ethics Policy. Any experimentation or research involving human or the use of animal samples must obtain approval from Human or Animal Ethics Committee in their respective institutions. The author(s) agree and understand that UNIMAS Publisher is not responsible for any compensational claims or failure caused by the author(s) in fulfilling the above-mentioned requirements. The author(s) must accept the responsibility for releasing their materials upon request by Chief Editor or UNIMAS Publisher.
6) The author(s) should have participated sufficiently in the work and ensured the appropriateness of the content of the article. The author(s) should also agree that he or she has no commercial attachments (e.g. patent or license arrangement, equity interest, consultancies, etc.) that might pose any conflict of interest with the submitted manuscript. The author(s) also agree to make any relevant materials and data available upon request by the editor or UNIMAS Publisher.
